newsNHS releases guidance to remove drugs from prescription list9 July 2019 | By Victoria Rees (European Pharmaceutical Review)Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
newsRevealed structure of glucagon fibrils could improve drug formulation27 June 2019 | By European Pharmaceutical ReviewResearchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.
newsGlobal diabetes drug market expected to rise 3.6 percent25 June 2019 | By Victoria Rees (European Pharmaceutical Review)A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
newsJob cuts limit cardiovascular and diabetes research and development25 June 2019 | By European Pharmaceutical ReviewPharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
newsAPI markets to grow 6.8 percent by 202630 May 2019 | By Victoria Rees (European Pharmaceutical Review)Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
newsBritish Columbia first province to switch patients to biosimilars30 May 2019 | By European Pharmaceutical ReviewBritish Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
newsReport shows US brand-name drug prices ‘highest in the world’7 May 2019 | By European Pharmaceutical ReviewA new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
newsReady-to-use glucagon for exercise-induced hypoglycaemia20 March 2019 | By European Pharmaceutical ReviewThis study will evaluate the ready-to-use, room-temperature stable liquid glucagon as a pre-treatment to prevent exercise-induced hypoglycemia...
newsStatins might be linked to increased risk of diabetes6 March 2019 | By European Pharmaceutical ReviewResearchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
newsLilly introduces cheaper generic insulin in the US5 March 2019 | By Nikki Withers (European Pharmaceutical Review)The generic version will cost 50 percent less that the current Humalog list price...
newsCompressed injection pill for oral insulin delivery8 February 2019 | By European Pharmaceutical ReviewA compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
newsCommittee demands answers on rising cost of insulin in the US1 February 2019 | By Nikki Withers (European Pharmaceutical Review)Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin...
newsCanagliflozin may not be associated with fracture risk in diabetes patients2 January 2019 | By European Pharmaceutical ReviewA study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
newsBig Data and AI provide better diagnosis and treatment26 November 2018 | By European Pharmaceutical ReviewMedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions...
newsInsulin supply chain transparency needed to prevent price hikes2 November 2018 | By Iqra Farooq (European Pharmaceutical Review)The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...